Folate antagonists as antibacterial and antiprotozoal agents.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000962:Antimalarials / Q000494:pharmacology; D000981:Antiprotozoal Agents / Q000494:pharmacology*; D004926:Escherichia coli / Q000187:drug effects; D005493:Folic Acid Antagonists / Q000494:pharmacology*; D005767:Gastrointestinal Diseases / Q000188:drug therapy; D006069:Gonorrhea / Q000188:drug therapy; D006801:Humans; D007780:Lacticaseibacillus casei / Q000187:drug effects / Q000201:enzymology; D008288:Malaria / Q000188:drug therapy; D010376:Pediococcus / Q000187:drug effects; D010961:Plasmodium / Q000187:drug effects / Q000201:enzymology; D011739:Pyrimethamine / Q000494:pharmacology; D012141:Respiratory Tract Infections / Q000188:drug therapy; D012874:Skin Diseases, Infectious / Q000188:drug therapy; D013420:Sulfamethoxazole / Q000627:therapeutic use; D014295:Trimethoprim / Q000494:pharmacology / Q000627:therapeutic use; D014345:Trypanosoma / Q000187:drug effects; D014552:Urinary Tract Infections / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D000962:Antimalarials; D000981:Antiprotozoal Agents; D005493:Folic Acid Antagonists; D014295:Trimethoprim; D013420:Sulfamethoxazole; D011739:Pyrimethamine